Tags

Type your tag names separated by a space and hit enter

What We Do Know and Do Not Yet Know about COVID-19 Vaccines as of the Beginning of the Year 2021.
J Korean Med Sci. 2021 Feb 08; 36(6):e54.JK

Abstract

Coronavirus disease 2019 (COVID-19), which started at the end of 2019 and has spread worldwide, has remained unabated in 2021. Since non-pharmaceutical interventions including social distancing are facing limitations in controlling COVID-19, additional absolute means to change the trend are necessary. To this end, coronavirus-specific antiviral drugs and vaccines are urgently needed, but for now, the priority is to promote herd immunity through extensive nationwide vaccination campaign. In addition to the vaccines based on the conventional technology such inactivated or killed virus or protein subunit vaccines, several vaccines on the new technological platforms, for example, nucleic acids-based vaccines delivered by viral carriers, nanoparticles, or plasmids as a medium were introduced in this pandemic. In addition to achieving sufficient herd immunity with vaccination, the development of antiviral treatments that work specifically against COVID-19 will also be necessary to terminate the epidemic completely.

Authors+Show Affiliations

Division of Infectious Diseases, Department of Internal Medicine, Bucheon St. Mary's Hospital, Bucheon, Korea. Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea. jhyoo@catholic.ac.kr.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

33559409

Citation

Yoo, Jin Hong. "What We Do Know and Do Not yet Know About COVID-19 Vaccines as of the Beginning of the Year 2021." Journal of Korean Medical Science, vol. 36, no. 6, 2021, pp. e54.
Yoo JH. What We Do Know and Do Not Yet Know about COVID-19 Vaccines as of the Beginning of the Year 2021. J Korean Med Sci. 2021;36(6):e54.
Yoo, J. H. (2021). What We Do Know and Do Not Yet Know about COVID-19 Vaccines as of the Beginning of the Year 2021. Journal of Korean Medical Science, 36(6), e54. https://doi.org/10.3346/jkms.2021.36.e54
Yoo JH. What We Do Know and Do Not yet Know About COVID-19 Vaccines as of the Beginning of the Year 2021. J Korean Med Sci. 2021 Feb 8;36(6):e54. PubMed PMID: 33559409.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - What We Do Know and Do Not Yet Know about COVID-19 Vaccines as of the Beginning of the Year 2021. A1 - Yoo,Jin Hong, Y1 - 2021/02/08/ PY - 2021/01/31/received PY - 2021/02/01/accepted PY - 2021/2/9/entrez PY - 2021/2/10/pubmed PY - 2021/2/10/medline KW - COVID-19 KW - Herd Immunity KW - Vaccine SP - e54 EP - e54 JF - Journal of Korean medical science JO - J Korean Med Sci VL - 36 IS - 6 N2 - Coronavirus disease 2019 (COVID-19), which started at the end of 2019 and has spread worldwide, has remained unabated in 2021. Since non-pharmaceutical interventions including social distancing are facing limitations in controlling COVID-19, additional absolute means to change the trend are necessary. To this end, coronavirus-specific antiviral drugs and vaccines are urgently needed, but for now, the priority is to promote herd immunity through extensive nationwide vaccination campaign. In addition to the vaccines based on the conventional technology such inactivated or killed virus or protein subunit vaccines, several vaccines on the new technological platforms, for example, nucleic acids-based vaccines delivered by viral carriers, nanoparticles, or plasmids as a medium were introduced in this pandemic. In addition to achieving sufficient herd immunity with vaccination, the development of antiviral treatments that work specifically against COVID-19 will also be necessary to terminate the epidemic completely. SN - 1598-6357 UR - https://www.unboundmedicine.com/medline/citation/33559409/What_We_Do_Know_and_Do_Not_Yet_Know_about_COVID_19_Vaccines_as_of_the_Beginning_of_the_Year_2021_ L2 - https://jkms.org/DOIx.php?id=10.3346/jkms.2021.36.e54 DB - PRIME DP - Unbound Medicine ER -